Mustang Bio, Inc. (MBIO): Price and Financial Metrics
MBIO Price/Volume Stats
Current price | $2.18 | 52-week high | $24.00 |
Prev. close | $2.32 | 52-week low | $0.89 |
Day low | $2.10 | Volume | 380,882 |
Day high | $2.29 | Avg. volume | 2,972,252 |
50-day MA | $1.48 | Dividend yield | N/A |
200-day MA | $0.00 | Market Cap | 9.54M |
MBIO Stock Price Chart Interactive Chart >
Mustang Bio, Inc. (MBIO) Company Bio
Mustang Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products based on the chimeric antigen receptor engineered T cell technology. Its lead programs include MB-101 for the treatment of brain cancer that is in Phase I trials; and MB-102, a therapeutic agent in acute myeloid leukemia, which is in Phase I trials. The company was founded in 2015 and is based in New York, New York. Mustang Bio Inc. is a subsidiary of Fortress Biotech, Inc.
MBIO Price Returns
1-mo | 103.74% |
3-mo | N/A |
6-mo | -60.72% |
1-year | -87.18% |
3-year | -99.53% |
5-year | -99.92% |
YTD | -75.37% |
2024 | -86.89% |
2023 | -77.21% |
2022 | -76.21% |
2021 | -56.14% |
2020 | -7.23% |
Continue Researching MBIO
Want to see what other sources are saying about Mustang Bio Inc's financials and stock price? Try the links below:Mustang Bio Inc (MBIO) Stock Price | Nasdaq
Mustang Bio Inc (MBIO) Stock Quote, History and News - Yahoo Finance
Mustang Bio Inc (MBIO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...